N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury
    1.
    发明授权
    N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury 失效
    用于治疗神经毒性损伤的N-(1-噻吩基环烷基)烯基胺

    公开(公告)号:US5604255A

    公开(公告)日:1997-02-18

    申请号:US344433

    申请日:1994-11-23

    CPC分类号: C07D409/06 C07D333/20

    摘要: Compounds, compositions and methods of treatment are described to control brain damage associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia. The treatment includes administration of an N-(1-thienylcycloalkyl)alkenylamine compound as an antagonist to inhibit excitotoxic actions at major neuronal excitatory amino acid receptor sites. Compounds of most interest are those of the formula ##STR1## wherein R.sup.1 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl and alkoxy; wherein each of R.sup.2 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl, oxo and alkoxy; wherein R.sup.5 is one or more groups selected from hydrido, alkyl of one to about five carbon atoms, cycloalkyl of three to about five carbon atoms, alkenyl of two to about five carbon atoms, hydroxyl and alkoxy; and wherein the broken line within the N-containing ring represents a double bond between any two adjacent carbon atoms

    摘要翻译: 描述了治疗的化合物,组合物和方法以控制与缺氧或缺血相关的脑损伤,其通常在中风,心脏骤停或围产期窒息之后。 治疗包括施用N-(1-噻吩基环烷基)链烯基胺化合物作为拮抗剂,以抑制主要神经元兴奋性氨基酸受体位点的兴奋性毒性作用。 最感兴趣的化合物是下式的化合物,其中R 1是一个或多个选自氢,烷基一至约五个碳原子,三至五个碳原子的环烷基,二至五个碳原子的烯基, 羟基和烷氧基; 其中R2各自为选自氢化物,1至约5个碳原子的烷基,3至约5个碳原子的环烷基,2至约5个碳原子的链烯基,羟基,氧代和烷氧基; 其中R5是一个或多个选自氢化的,一至五个碳原子的烷基,三个至五个碳原子的环烷基,二个至五个碳原子的烯基,羟基和烷氧基的基团; 并且其中所述含N环内的虚线表示任意两个相邻碳原子之间的双键